DSP and neoplasm: Recent recognition of immunogenic chemotherapy showed that some cytotoxic agents, including doxorubicin, cyclophosphamide, and oxaliplatin, can enhance the population of tumor-infiltrating lymphocytes through the induction immunogenic cell death (ICD) (Obeid et al, 2007; Tesniere et al, 2010), enabling immune cell-mediated modulation of DSP in the TME.